Susquehanna Fundamental Investments’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $104K | Hold |
909
| – | – | ﹤0.01% | 1447 |
|
|
2021
Q4 | $131K | Sell |
909
-448
| -33% | -$64.6K | ﹤0.01% | 1307 |
|
|
2021
Q3 | $297K | Sell |
1,357
-90
| -6% | -$19.7K | 0.01% | 1412 |
|
|
2021
Q2 | $336K | Buy |
1,447
+1,054
| +268% | +$245K | 0.01% | 1324 |
|
|
2021
Q1 | $118K | Sell |
393
-257
| -40% | -$77.2K | ﹤0.01% | 1451 |
|
|
2020
Q4 | $244K | Sell |
650
-289
| -31% | -$108K | ﹤0.01% | 1314 |
|
|
2020
Q3 | $288K | Buy |
939
+833
| +786% | +$255K | 0.01% | 1077 |
|
|
2020
Q2 | $40K | Buy |
+106
| New | +$40K | ﹤0.01% | 947 |
|